Related Experiment Videos
Podoplanin as a marker for mesothelioma
1Department of Pathology and Laboratory Medicine, Tohoku Rosai Hospital, Japan Labor Health and Welfare Organization, 21-3-4 Dainohara Aoba-ku, Sendai 981-8563, Japan. nkimura-path@tohokuh.rofuku.go.jp
Pathology International
|February 8, 2005
Summary
Podoplanin, a marker for lymphatic endothelial cells, shows promise as a diagnostic tool for mesothelioma. This study found podoplanin specifically expressed in malignant mesothelioma, not other common tumors, indicating high diagnostic potential.
Area of Science:
- Oncology
- Histopathology
- Immunohistochemistry
Background:
- Podoplanin is a known marker for lymphatic endothelial cells.
- Expression of podoplanin has been observed in reactive mesothelial cells.
- Its diagnostic utility in differentiating tumors, particularly mesothelioma, requires investigation.
Purpose of the Study:
- To evaluate the diagnostic utility of podoplanin as a tumor marker for malignant mesothelioma.
- To assess the specificity and sensitivity of podoplanin in distinguishing mesothelioma from other neoplasms.
Main Methods:
- Immunohistochemical analysis of podoplanin expression.
- Study included five cases of malignant mesothelioma and 118 other tumor types (adenocarcinomas, squamous cell carcinomas, GISTs, endocrine tumors).
Main Results:
- All five malignant mesotheliomas exhibited positive podoplanin immunoreactivity on the tumor cell membrane.
- None of the 118 other tumors evaluated showed positive podoplanin staining.
- Podoplanin demonstrated high specificity in this cohort.
Conclusions:
- Podoplanin is a highly specific marker for malignant mesothelioma.
- It holds significant potential as an excellent tumor marker for mesothelioma diagnosis, complementing existing antibodies.
- Further studies are warranted to confirm its utility in clinical practice.